Michael Davidson
Chief Executive Officer
Replay available
NewAmsterdam Pharma Company N.V. (NAMS) Q2 2026 Earnings Call
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Kastelein
Chief Scientific Officer
BJ Jones
Chief Commercial Officer
Ian Somaiya
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Newamsterdam Pharma Company N.v..
Replay transcript excerpt
WEBVTT 00:00:00.071 -- 00:00:05.593 Good morning, everybody. Thank you for joining us today for our annual investor day. 00:00:05.593 -- 00:00:10.894 I'm pleased to have Michael Davidson, our CEO, John Kastelein, our chief scientific officer, 00:00:10.894 -- 00:00:15.655 and BJ Jones, our chief commercial officer, here with us today speaking, along with many 00:00:15.655 -- 00:00:20.757 members of our team. Ian Somaiya will also be available for questions afterwards 00:00:20.757 -- 00:00:22.698 for the presentation. 00:00:22.698 -- 00:00:27.564 Before we get started, The fun part, we will be making forward-looking statements today. 00:00:27.564 -- 00:00:32.053 I would advise everyone to please read our forward-looking statement page either here 00:00:32.053 -- 00:00:36.859 in the room or also available online at this time. 00:00:37.988 -- 00:00:43.850 As we mentioned, today we'll have Michael going through a general corporate update and 00:00:43.850 -- 00:00:48.852 introduction. We'll have John presenting the science, then we'll go back to Michael for 00:00:48.852 -- 00:00:54.094 an update on Pervail, as well as some of the updates on AD, and then BJ 00:00:54.094 -- 00:00:56.475 will be going through commercial. 00:00:56.475 -- 00:01:01.797 At this time, I'd like to have Michael come up and join us. 00:01:01.797 -- 00:01:03.797 Michael. 00:01:10.068 -- 00:01:12.971 Thank you, Matt, and thanks, everyone, for being here. 00:01:12.971 -- 00:01:18.136 We're very excited to share with you our science and corporate update. 00:01:18.136 -- 00:01:23.501 For us, this is our third Investor Day Science Day, and for John and I, 00:01:23.501 -- 00:01:25.363 it's one of our favorite days of the year. 00:01:25.363 -- 00:01:31.066 We get a chance to talk to you about what we're doin...